Kevin Balthaser
Chief Financial Officer · 4 filings · Latest: Mar 1, 2026
Aclaris Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ACRS | Kevin Balthaser | Chief Financial Officer | Mar 1, 2026 | Option Exercise | — | 2,375 | — | 188,130 | |
ACRS | Kevin Balthaser | Chief Financial Officer | Feb 3, 2026 | Option Exercise | — | 22,025 | — | 192,204 | |
ACRS | Kevin Balthaser | Chief Financial Officer | Feb 1, 2026 | Option Exercise | — | 14,750 | — | 175,163 |